Correlation Between Cingulate and Panbela Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate and Panbela Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate and Panbela Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate and Panbela Therapeutics, you can compare the effects of market volatilities on Cingulate and Panbela Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate with a short position of Panbela Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate and Panbela Therapeutics.
Diversification Opportunities for Cingulate and Panbela Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cingulate and Panbela is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and Panbela Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Panbela Therapeutics and Cingulate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate are associated (or correlated) with Panbela Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Panbela Therapeutics has no effect on the direction of Cingulate i.e., Cingulate and Panbela Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate and Panbela Therapeutics
If you would invest 383.00 in Cingulate on September 3, 2024 and sell it today you would earn a total of 53.00 from holding Cingulate or generate 13.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 5.0% |
| Values | Daily Returns |
Cingulate vs. Panbela Therapeutics
Performance |
| Timeline |
| Cingulate |
| Panbela Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cingulate and Panbela Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate and Panbela Therapeutics
The main advantage of trading using opposite Cingulate and Panbela Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate position performs unexpectedly, Panbela Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Panbela Therapeutics will offset losses from the drop in Panbela Therapeutics' long position.| Cingulate vs. SAB Biotherapeutics | Cingulate vs. Senti Biosciences | Cingulate vs. Aerovate Therapeutics | Cingulate vs. Adagene |
| Panbela Therapeutics vs. ZyVersa Therapeutics | Panbela Therapeutics vs. Sonnet Biotherapeutics Holdings | Panbela Therapeutics vs. Revelation Biosciences | Panbela Therapeutics vs. Altamira Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |